Search

everythinglearnresearchcommunity

for

Search:↓

Hyperandrogenism is diagnosed using clinical signs, lab tests, and imaging.

High prolactin levels can cause skin and hair symptoms similar to those caused by hormone imbalances.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Glucocorticoids can cause long-term loss of body hair by lowering adrenal androgens.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

Antiandrogens are used to manage polycystic ovary syndrome by reducing androgen levels or controlling their effects, often combined with lifestyle changes and other treatments.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Polycystic ovary syndrome affects health and can be hard to diagnose, with treatments ranging from drugs to herbal remedies.

PCOS women have more arm fat and higher insulin resistance and glucose levels than non-PCOS women.

A woman with non-classic CAH had unusual heavy periods and high hormone levels, improved with treatment.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Accurate diagnosis of PCOS requires comprehensive androgen measurement.

Women with hirsutism have different levels of omentin-1, which may be linked to the condition and its genetic aspects.

Both oral contraceptives reduced hirsutism in PCOS patients, but adding metformin showed no extra benefit.

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Women with PCOS have lower zinc levels.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

Weight loss can lower AMH levels in overweight and obese women with PCOS.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.